According to the sources, The DCGI (The Drugs Controller General of India) granted permission to Mukesh Ambani-owned Reliance Life Sciences to conduct its COVID-19 vaccine trial on friday with certain conditions. The safety, tolerability and immunogenicity of the SARS-CoV-2 recombinant protein subunit vaccine in healthy